PCM
GBIO

Penserra Capital Management’s Generation Bio GBIO Stock Holding History

Penserra Capital Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-130
Closed -$32K – 1427
2021
Q3 		$32K Buy
130
+1
+0.8% +$239 ﹤0.01% 1170
2021
Q2 		$34K Buy
129
+6
+5% +$1.79K ﹤0.01% 1076
2021
Q1 		$35K Buy
123
+15
+14% +$4.8K ﹤0.01% 874
2020
Q4 		$30K Buy
+108
New +$34.7K ﹤0.01% 779

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Penserra Capital Management's GBIO Position: Q4 2021 in Review

Penserra Capital Management sold out of Generation Bio (GBIO) in Q4 2021, closing a stake of 130 shares — an estimated $32K sold.

Penserra Capital Management first reported a position in GBIO in Q4 2020 and held it in 4 quarters. The position peaked at $35K in Q1 2021. 88 funds tracked by Wall St. Rank hold GBIO as of Q4 2021.

  • Penserra Capital Management reported no remaining Generation Bio position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 130 Generation Bio shares in Q4 2021, an estimated $32K.
  • Penserra Capital Management first reported a position in Generation Bio in Q4 2020 and held it in 4 quarters.
  • Penserra Capital Management's Generation Bio position peaked at $35K in Q1 2021.
  • 88 funds tracked by Wall St. Rank held Generation Bio as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.